Ligand validation:3AG3

TGL: TRISTEAROYLGLYCEROL

TGL is a Ligand Of Interest in 3AG3 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3AG3_TGL_A_521	25%	23%	0.18	0.814	1.36	1.78	6	13	15	0	100%	1
3AG3_TGL_O_1521	24%	23%	0.168	0.798	1.42	1.74	6	12	17	0	100%	1
3AG3_TGL_L_522	13%	14%	0.227	0.767	1.7	2.16	7	16	21	0	100%	1
3AG3_TGL_D_523	12%	21%	0.202	0.735	1.59	1.74	7	15	9	0	100%	1
3AG3_TGL_Q_1523	10%	26%	0.22	0.719	1.53	1.47	7	9	19	0	100%	1
3AG3_TGL_N_1522	5%	17%	0.252	0.647	1.67	1.95	10	17	19	0	100%	1
5B1A_TGL_B_301	58%	8%	0.119	0.898	1.71	2.82	8	21	4	0	100%	1
5ZCQ_TGL_A_608	51%	22%	0.146	0.899	1.36	1.87	5	11	1	0	100%	1
5ZCP_TGL_A_608	49%	17%	0.149	0.895	1.31	2.24	6	10	9	0	100%	1
5B3S_TGL_B_301	48%	36%	0.154	0.897	1.1	1.4	3	6	11	0	100%	1
6JUW_TGL_A_610	48%	36%	0.137	0.878	1.18	1.34	3	6	4	0	100%	1
7W3E_TGL_B_301	46%	30%	0.145	0.881	1.18	1.61	3	9	10	0	98%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.